2026 SPEAKERS
Felix Arellano, Senior Vice President, Global Head of Safety and Risk Management, Roche
Tea Babic, Director, Head of PV Audits and Inspections, Deputy Head PV Compliance, Teva Pharmaceuticals
Begum Benli Peker, Director, Head of Patient Safety Netherlands & EU Hub Lead, Bristol Myers Squibb
Mariette Boerstoel, Senior Vice President, Worldwide Patient Safety Officer, Bristol Myers Squibb
Gloria Bustos, Global Head, Global Patient Safety, Vantive
Pedro Caetano, Senior Safety Physician, Oncology, Global Patient Safety, Debiopharm International
Natacha Carragher, Senior Advisor, Pharmacoepidemiology, Global Patient Safety, Eli Lilly
Nicola Charpentier, Vice President, Head of Benefit Risk Management, Medical Safety and Pharmacovigilance, BioNTech
Mijal Chavda, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin International
Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics
Michelle Motta Dardeno, Vice President, Head of Global Patient Safety, Aurinia
Fabio De Gregorio, Vice President, Head of Drug Safety Europe, Shionogi BV
Tasia-Leigh Deleon, Manager of Cosmetovigilance, CHANEL
Francesca Dickins, Advisor, Medicines Quality Organization, Eli Lilly
Marjan Dzeparoski, RA and PV Manager & Lecturer, Medicine Faculty, Bionika Pharmaceuticals & Goce Delčev University of Štip
Vicki Edwards, Vice President, Pharmacovigilance Excellence & International QPPV, AbbVie
Giovanni Furlan, Head, Medical Safety Operations, Sandoz
Magda Godula, Director, Regional Safety Platform Lead, Pfizer
Pedro Gomes, Global Director, Pharmacovigilance (PV) Quality Assurance Lead, MSD
Pat Harding, Senior Director, International PV Operations (PSMF), Eli Lilly and Company
Annette Humes, Chief of Staff, Global Head of Safety Resource and Alliance Management, Roche
Sława Janczewska, Associate Director, Clinical Data Management, MSD
Smruti Kothari, Associate Director, Global Patient Safety, Quality and Compliance, Regeneron
Marcin Kruk, Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East, Pfizer
Thomas Kuckuk, Head Pharmacovigilance Systems Management, Novartis
Claudia Lehmann, Head, Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International
Ewa Malinowska, Associate Director, Clinical Data Management, MSD
Mr Bruno Mendez, Global Head, Pharmacovigilance Quality, Sanofi
Yvonne Nanciu, EU QPPV Deputy, Country Head Pharmacovigilance, Germany and Austria, Bayer
Magnus Nord, Vice President, Global Patient Safety BioPharma, AstraZeneca
Kieran O'Donnell, Director, Independent PV Expert
Tjark Reblin, Senior Vice President, Global Head of Patient Safety, Ipsen
Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Amy Ryan, Director, Patient Safety Inspection Excellence, AstraZeneca
Monika Sarnecka, Associate Director, Clinical Data Management, MSD
Rudi Scheerlinck, Global Program Safety Lead, Merck Healthcare Oncology
Jens-Ulrich Stegmann, Senior Vice President, Head Clinical Safety and Pharmacovigilance, EU QPPV, GSK
Mary Lynne van Poelgeest-Pomfret, President, World Federation for Incontinence and Pelvic Problems (WFIPP)
Deepa Venkataraman, Vice President, Head of Patient Safety and Pharmacovigilance, Corcept Therapeutics
Michael von Forstner, Chief Scientific Officer, MedGenie
Dany Ward, Executive Director, Head of PV Ops & Global Risk Management, Jazz Pharmaceuticals
Heinz Weidenthaler, Senior Director, Safety Strategy Lead, BioNTech
Dieter Wetzel, Head of Medical Science, toclinco GmbH
Anna Wieczner, Associate Director, Clinical Data Management, MSD
Aya Zaghloul, Associate Director, Global Patient Safety, Eli Lilly and Company
Dimitrios Zampatis, Director, Product Patient Safety, Sandoz
Get Involved At
World Drug Safety Congress
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events